Suppr超能文献

疟原虫与人宿主之间二氢叶酸还原酶的不同调控

Divergent regulation of dihydrofolate reductase between malaria parasite and human host.

作者信息

Zhang Kai, Rathod Pradipsinh K

机构信息

Department of Biology, The Catholic University of America, Washington, DC 20064, USA.

出版信息

Science. 2002 Apr 19;296(5567):545-7. doi: 10.1126/science.1068274.

Abstract

For half a century, successful antifolate therapy against Plasmodium falciparum malaria has been attributed to host-parasite differences in drug binding to dihydrofolate reductase-thymidylate synthase (DHFR-TS). Selectivity may also arise through previously unappreciated differences in regulation of this drug target. The DHFR-TS of Plasmodium binds its cognate messenger RNA (mRNA) and inhibits its own translation. However, unlike translational regulation of DHFR or TS in humans, DHFR-TS mRNA binding is not coupled to enzyme active sites. Thus, antifolate treatment does not relieve translational inhibition and parasites cannot replenish dead enzyme.

摘要

半个世纪以来,针对恶性疟原虫疟疾的成功抗叶酸治疗一直归因于宿主与寄生虫在药物与二氢叶酸还原酶 - 胸苷酸合成酶(DHFR - TS)结合方面的差异。选择性也可能源于此前未被重视的该药物靶点调控差异。疟原虫的DHFR - TS与其同源信使核糖核酸(mRNA)结合并抑制自身翻译。然而,与人类中DHFR或TS的翻译调控不同,DHFR - TS mRNA结合并不与酶活性位点偶联。因此,抗叶酸治疗不能解除翻译抑制,寄生虫无法补充死亡的酶。

相似文献

引用本文的文献

1
Covalent inhibition of Ubc13 impairs global protein synthesis.对Ubc13进行共价抑制会损害整体蛋白质合成。
iScience. 2025 Apr 28;28(6):112545. doi: 10.1016/j.isci.2025.112545. eCollection 2025 Jun 20.
9
Indispensable malaria genes.不可或缺的疟疾基因。
Science. 2018 May 4;360(6388):490-491. doi: 10.1126/science.aat5092.

本文引用的文献

2
The intolerable burden of malaria: a new look at the numbers.疟疾的沉重负担:重新审视相关数据。
Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2 Suppl):iv-vii. doi: 10.4269/ajtmh.2001.64.iv.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验